Health Care Technology

YIDU TECH

Yidu Tech Subsidiary Wins Tianjin Tumor Hospital Project Worth Approx 7.39 Million RMB

Yidu Tech Wins Major Singapore and Domestic Hospital Contracts, Forecasts Profitability

Yidu Cloud Wins Bid for Chongqing University Affiliated Fuling Hospital Data Center Project, Contract Value Approximately 9.65 Million RMB

Yidu Cloud and Zhongshan University's Cancer Center Jointly Showcase Medical AI Products

Yidu Tech Secures 9.08 Million Yuan Contract for Smart Clinical Upgrade Project at Sun Yat-sen University Cancer Center

MedyAxis Continues as the Main Operator of Shenzhen's People's Benefit Insurance for Four Years

Yidu Tech Wins Singapore Health Services Pte Ltd Project

Yidu Cloud Wins PIONEER2 Project Bid from Guangzhou Medical University's First Affiliated Hospital

Yidu Tech Poised for First Annual Profit, Marks Inflection Point for AI-Powered Healthcare Sector

Yidu Technology Completes DeepSeek-V4 Integration Enhancing Clinical Evidence Capabilities

Yidu Technology Achieves First Full-Year Profitability

YiduTech Reports Profit Guidance, Pushes for Deep Integration of Large Model Technology

YiduTech wins the construction project of Hainan Smart Health Island

Medical AI New Product Launch by Yidu Cloud

Yidu Tech Expected to Turn Profit with Net Income of 55 to 70 Million RMB

YiduTech Wins Multiple AI Projects and Gets Citibank Buy Rating

Citi Releases Report on Yidu Tech Valuation Analysis with Buy Rating

MedyMatch Technology Repurchased 2.67 Million Shares in Hong Kong

Yidu Technology repurchased 1,908,800 shares for HKD 11.2844 million

Medtech releases 'Medtrac Intelligent Body' and deepens cooperation with Hainan Boao Lecheng

I.CENTURY HLDG

RIVERINE CHINA

KOS TALENT GP

CHINA CBS INTL

NATURE ENERGY T

DIGIT HOLLYWOOD

REDCO HEALTHY

ZXZN QI-HOUSE

ASIA PIONEER

HUISHENG INTL

02158

Yidu Tech, Inc. has announced that its affiliate, Yidu Cloud, won a RMB7.39 million bid to develop an AI-driven clinical research platform for Tianjin Medical University Cancer Institute and Hospital. This project highlights Yidu Tech's expanding role in precision healthcare and its commitment to enhancing clinical decision-making through AI technology.

- Yidu Tech, Inc. has announced that its affiliate Yidu Cloud won a bid to develop an intelligent clinical research platform for Tianjin Medical University Cancer Institute and Hospital for approximately RMB 7.39 million.  
- This contract highlights Yidu Tech's expanding role in AI-driven healthcare, enhancing its relationships within the cancer treatment ecosystem and supporting its goal of advancing precision healthcare in China.  
- The project is expected to validate the company's AI models and improve its clinical research capabilities while aiming to make precision medicine more accessible.

Tip Ranks

Yidu Tech Wins RMB7.39 Million AI Clinical Research Platform Bid in Tianjin

GS-A

GS-D

GS-C

Yidu Tech, Inc. has invested in low-risk wealth management products from China Merchants Bank, Ping An Bank, and Goldman Sachs, with returns between 2.5% and 5%. The investments, totaling over 200 million renminbi, aim to enhance capital utilization and liquidity management while preserving shareholder value. Yidu Tech focuses on healthcare technology, leveraging data analytics for improved medical solutions.

- Yidu Tech, Inc. has updated investors on its subscription to short-term wealth management products from China Merchants Bank, Ping An Bank, and Goldman Sachs.  
- These structured deposits, ranging from tens of millions to over 200 million renminbi, aimed to enhance capital utilization with annualized returns of 2.5% to over 5%.  
- By investing idle cash in low-risk instruments, the company seeks to improve financial returns and liquidity management while maintaining shareholder risk.

GOLDMAN SACHS GROUP INC DEP SHR REP 1/1000TH PFD SER A

GOLDMAN SACHS GROUP INC DEP REP 1/1000TH PRF D

Goldman Sachs

GOLDMAN SACHS GROUP INC DEP SHS REPSTG 1/1000TH PRF SER C

CM BANK

China Merchants Bank

GS Hldg R

Yidu Tech Deploys Idle Cash Into Low-Risk Wealth Management Products

Yesterday, YIDU TECH's stock price fell sharply by 6.95%, closing at HKD 5.89, with weak performance throughout the day and clear dominance by short sellers. Although the MACD daily chart previously formed a bullish signal, the significant drop in stock price puts this signal under severe test, and this divergence between technical indicators and price movements usually indicates low market confidence in the signal. The trading volume was approximately HKD 60.05 million, and the increase in volume during the decline suggests that a considerable amount of capital chose to exit at this position. The TTM price-to-earnings ratio is -69.67 times, and the company is still in a loss-making phase, with limited fundamental support. On the news front, YIDU TECH focuses on medical big data and AI technology services. Although the AI medical concept was once favored in the Hong Kong stock market, there remains significant disagreement regarding the speed of its commercialization and profitability timeline. Recently, the technology sector in the Hong Kong stock market has been under pressure, with leading companies like Tencent and Meituan experiencing varying degrees of pullback, and the outflow of funds from the sector has a more pronounced negative impact on small and mid-cap AI concept stocks. Additionally, the central bank's monetary policy report suggests a neutral liquidity environment, adding extra pressure on high-valuation, high-uncertainty loss-making tech stocks. From a technical perspective, yesterday's large bearish candle has engulfed most of the previous days' rebound gains, and the stock price has fallen below short-term moving average support, significantly damaging the technical pattern. The HKD 5.80 level is a key support in the near term; if it continues to break down today, it may test HKD 5.50 or even lower. The unfavorable volume-price relationship makes short-term recovery difficult. The short-term trend is biased towards bearishness, and the validity of bullish signals is in doubt, requiring observation of whether it can stabilize around HKD 5.80

- Yesterday, the stock price of Yidu Tech fell by 6.95%, closing at 5.89 HKD, with bearish sentiment dominating the market.  
- Although the MACD daily line issued a bullish signal previously, the sharp decline challenges its credibility, indicating low market confidence in this signal.  
- Yidu Tech, which focuses on medical big data and AI services, faces negative impacts from overall market pressures, and the stock's short-term outlook remains bearish with critical support at 5.80 HKD.

Technical Forecast

TENCENT

Tencent

MEITUAN

Meituan

TENCENT-R

Tencent HK SDR 10to1

Tencent Holdings Limited

MEITUAN-WR

Meituan HK SDR 5to1

Pre-market trend | YIDU TECH (2158.HK) dropped nearly 7% on May 12 with increased volume, is the signal facing headwinds?

Yidu Tech Inc. has secured a contract worth approximately RMB9.08 million for a Smart Clinical Upgrade Project at Sun Yat-sen University Cancer Center. This project highlights Yidu Tech's role in AI-driven clinical solutions, enhancing efficiency in medical decision-making and financial processes. The contract strengthens Yidu Tech's competitive position in China's smart healthcare market and adds to its project backlog, supporting its strategy of integrating AI into healthcare workflows.

- Yidu Tech, Inc. has announced a contract valued at approximately RMB 9.08 million for a project at Sun Yat-sen University Cancer Center, focusing on AI-driven clinical solutions.  
- This initiative is part of Yidu Tech's strategy to enhance healthcare efficiency and precision in medical and financial processes.  
- The contract not only expands Yidu Tech’s project backlog but also demonstrates the commercial viability of its intelligent healthcare solutions in China's evolving market.

BANK OF CHINA

Bank Of China

BOC HONG KONG

Bank of China

Yidu Tech Wins RMB9 Million Smart Clinical Upgrade Project at Sun Yat-sen University Cancer Center

Yidu Tech, Inc. has secured a SGD 2.28 million contract from Singapore Health Services Pte Ltd through its subsidiary EVYD Research Private Limited. This contract is part of Yidu Tech's expansion into Singapore, focusing on the Dr Buddy platform, which utilizes AI for clinical decision-making and precision healthcare. The project aims to enhance healthcare delivery efficiency and accuracy, while also fostering partnerships with various stakeholders in the healthcare sector. Yidu Tech specializes in AI-driven healthcare solutions, aiming to improve China's healthcare system.

- Yidu Tech, Inc. has announced a contract worth SGD 2.28 million with Singapore Health Services to support the Dr Buddy platform.  
- This deal signifies Yidu Tech's expansion into Singapore, enhancing its AI-driven healthcare solutions beyond China.  
- The project aims to improve care delivery efficiency and accuracy, positioning Yidu Tech as a key player in data-driven healthcare in Asia.

Yidu Tech Wins SGD 2.28 Million Dr Buddy Contract in Singapore Expansion Push

Yidu Tech Inc. expects to post its first annual profit, projecting a net profit of $6 million to $8 million for the financial year ending March, marking a potential turning point for AI in healthcare. The company has seen increased adoption of its AI tools in medical workflows, with some hospitals using them nearly 1,000 times daily. Despite this, the outlook for sustained profits remains uncertain due to slow revenue growth and dependency on hospital procurement cycles. Following the announcement, Yidu Tech's shares rose 3.8%.

- Yidu Tech Inc. expects to post its first annual profit with projections between $6 million and $8 million for the financial year ending in March, aided by increased AI tool adoption in hospitals.  
- Despite a positive turnaround from previous losses, revenue growth remains in single digits, and there are concerns about the sustainability of profits amid varying adoption rates and external factors.  
- The company’s recent success may indicate potential for monetization in AI healthcare, but the overall outlook remains uncertain as it seeks to establish a proven business model.

benzinga_article

Yidu Tech Swings To Profit Signaling An Inflection Point For AI Healthcare

YIDU TECH forecasts its first annual profit, becoming one of the few profitable cases in the medical AI industry. The expected net profit is between 41 million and 56 million yuan, with the turnaround from loss to profit attributed to the integration of AI capabilities into products driving an increase in new orders and improved gross margins. The company's interim results show revenue growth and a significant reduction in operating losses, with the main growth drivers coming from hospital and payment-side businesses. The market holds a cautious attitude towards the commercialization prospects of medical AI, focusing on the application and returns of AI in actual processes

BambooWorks

XUNFEIHEALTH

AIRDOC-B

AI medical concept landing? YIDU TECH achieves annual profitability for the first time

Yidu Tech, Inc. (HK:2158) forecasts a return to profitability with an expected net profit of RMB55 million to RMB70 million for the fiscal year ending March 31, 2026, compared to a net loss of RMB135.2 million the previous year. The turnaround is attributed to increased orders and AI integration in products, leading to higher gross margins and operational efficiencies. The company focuses on AI-powered solutions and aims to enhance competitiveness and profitability in data-driven applications.

- Yidu Tech, Inc. expects to report a net profit of approximately RMB55 million to RMB70 million for the fiscal year ending March 31, 2026, a significant improvement from a net loss of about RMB135.2 million the previous year.  
- The anticipated profit is attributed to increased new orders in core segments and enhancements from AI integration, leading to higher gross margins and operational efficiencies.  
- This financial turnaround suggests a stronger market position for Yidu Tech, which specializes in AI-powered solutions and operates in data-driven applications.

Yidu Tech Forecasts Return to Profit on AI-Driven Growth and Margin Gains

YIDU TECH(02158.HK)